Follow
Karwan Moutasim
Karwan Moutasim
Consultant Pathologist, University Hospital Southampton
Verified email at soton.ac.uk - Homepage
Title
Cited by
Cited by
Year
Stromal features are predictive of disease mortality in oral cancer patients
D Marsh, K Suchak, KA Moutasim, S Vallath, C Hopper, W Jerjes, T Upile, ...
The Journal of pathology 223 (4), 470-481, 2011
3612011
Targeting the myofibroblastic cancer-associated fibroblast phenotype through inhibition of NOX4
CJ Hanley, M Mellone, K Ford, SM Thirdborough, T Mellows, SJ Frampton, ...
JNCI: Journal of the National Cancer Institute 110 (1), 109-120, 2018
1582018
Betel‐derived alkaloid up‐regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis
KA Moutasim, V Jenei, K Sapienza, D Marsh, PH Weinreb, SM Violette, ...
The Journal of pathology 223 (3), 366-377, 2011
1292011
Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis
M Mellone, CJ Hanley, S Thirdborough, T Mellows, E Garcia, J Woo, ...
Aging (Albany NY) 9 (1), 114, 2017
1152017
Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation
LF Yap, V Jenei, CM Robinson, K Moutasim, TM Benn, SP Threadgold, ...
Oncogene 28 (27), 2524-2534, 2009
952009
Cell migration and invasion assays
KA Moutasim, ML Nystrom, GJ Thomas
Cancer Cell Culture: Methods and Protocols, 333-343, 2011
732011
Evaluating the effect of immune cells on the outcome of patients with mesothelioma
SJ Chee, M Lopez, T Mellows, S Gankande, KA Moutasim, S Harris, ...
British journal of cancer 117 (9), 1341-1348, 2017
572017
HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma
JC Fleming, J Woo, K Moutasim, M Mellone, SJ Frampton, A Mead, ...
British journal of cancer 120 (3), 356-367, 2019
532019
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
S Pugh, R Thiébaut, J Bridgewater, ML Grisoni, K Moutasim, F Rousseau, ...
Oncotarget 8 (55), 93856, 2017
522017
A comparison of primary oesophageal squamous epithelial cells with HET‐1A in organotypic culture
TJ Underwood, MF Derouet, MJ White, F Noble, KA Moutasim, E Smith, ...
Biology of the Cell 102 (12), 635-644, 2010
522010
In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts
NMH McLeod, KA Moutasim, PA Brennan, G Thomas, V Jenei
Journal of Oral and Maxillofacial Surgery 72 (3), 503-509, 2014
372014
Pro‐migratory and TGF‐â‐activating functions of ávâ6 integrin in pancreatic cancer are differentially regulated via an Eps8‐dependent GTPase switch
J Tod, CJ Hanley, MR Morgan, M Rucka, T Mellows, MA Lopez, P Kiely, ...
The Journal of pathology 243 (1), 37-50, 2017
332017
Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer …
K Packwood, G Martland, M Sommerlad, E Shaw, K Moutasim, G Thomas, ...
The Journal of Pathology: Clinical Research 5 (3), 189-198, 2019
322019
Orofacial presentations of sarcoidosis–a case series and review of the literature
TWJ Poate, R Sharma, KA Moutasim, MP Escudier, S Warnakulasuriya
British dental journal 205 (8), 437-442, 2008
302008
A case of vulvovaginal gingival lichen planus in association with Good¢s syndrome
KA Moutasim, TWJ Poate, JF Setterfield, SJ Challacombe
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2008
302008
Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC
R Sreekumar, M Emaduddin, H Al-Saihati, K Moutasim, J Chan, ...
Cell death & disease 10 (10), 703, 2019
292019
Assessment of nuclear ZEB2 as a biomarker for colorectal cancer outcome and TNM risk stratification
R Sreekumar, S Harris, K Moutasim, R DeMateos, A Patel, K Emo, ...
JAMA network open 1 (6), e183115-e183115, 2018
292018
The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal …
R Sreekumar, H Al‐Saihati, M Emaduddin, K Moutasim, M Mellone, ...
Molecular Oncology 15 (8), 2065-2083, 2021
252021
Papillary and verrucous lesions of the oral mucosa
KA Moutasim, GJ Thomas, AW Barrett
Diagnostic Histopathology 23 (6), 243-249, 2017
232017
Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays
J Lawson, RJ Robinson-Vyas, JP McQuillan, A Paterson, S Christie, ...
British journal of cancer 116 (2), 237-245, 2017
202017
The system can't perform the operation now. Try again later.
Articles 1–20